Psychiatric Manifestations of ATP13A2 Mutations.

Bettina BalintJoana DamasioFrancesca MagrinelliRita GuerreiroJose BrasKailash P Bhatia

Published in: Movement disorders clinical practice (2020)

Prominent behavioral or psychiatric features can be the first or most prominent manifestation of ATP13A2-related disease. They may be a diagnostic clue in patients with ataxia, spasticity, or parkinsonism and may require an interdisciplinary neurological and psychiatric treatment approach.

Keyphrases

mental health
spinal cord injury
parkinson disease
early onset
drug induced
botulinum toxin
upper limb
deep brain stimulation